Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/11/24 17:53 | 9/10/24 | HUMA | Health | BioPrd | Biological Products, (No Diag | Sebelius Kathleen | NC | D | 1 | S.d | -28 | 5.40 | 0 | -5 | 41 | D | ||||||||||||||||
9/11/24 17:52 | 9/9/24 | HUMA | Health | BioPrd | Biological Products, (No Diag | Dougan Brady W | NC | D | 2 | S.m | -8,089 | 6.09 | 0 | -1,328 | 5,576 | I | ||||||||||||||||
9/11/24 17:50 | 9/9/24 | HUMA | Health | BioPrd | Biological Products, (No Diag | Niklason Laura E | NC | DO | P,CEO,Di | 2 | S.m | -8,089 | 6.09 | 0 | -1,328 | 5,576 | I | |||||||||||||||
8/29/24 18:45 | 8/27/24 | HUMA | Health | BioPrd | Biological Products, (No Diag | Sander Dale A. | NC | O | CFO,Chie | 1 | S.d | -263 | 6.68 | 0 | -39 | 23 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |